A COMPOSITION COMPRISING BLOOD PLASMA AND IMMUNOGLOBULINS FOR USE IN THE TREATMENT OR PREVENTION OF AN INFECTIOUS DISEASE

NOBLE COLD-ADAPTED ATTENUATED MERS-COV

METHOD OF VACCINATION WITH AN ATTENUATED RSV VACCINE FORMULATION

MODULAR BACTERIOPHAGE T4 NANOPARTICLE PLATFORM ENABLES RAPID DESIGN OF DUAL COVID-19-FLU MUCOSAL VACCINES

METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER

METHODS FOR TREATING OR PREVENTING RESPIRATORY DISEASES IN CATTLE USING POLYMERS AND POLYPLEXES FOR mRNA DELIVERY AND mRNA THERAPY

TARGETING moDC TO ENHANCE VACCINE EFFICACY ON MUCOSAL SURFACE

PIV5-BASED COVID-19 VACCINE

RECOMBINANT PROTEIN AND PREPARATION PROCESS THEREOF, PROTEIN ADJUVANT FOR VACCINE COMPRISING RECOMBINANT PROTEIN, AND USE OF RECOMBINANT PROTEIN FOR PREVENTING RESPIRATORY DISEASE

INFLUENZA VIRUS VACCINATION REGIMENS

PHARMACEUTICAL COMPOSITION FOR RESISTING INFECTION WITH SARS-COV-2 OR MUTANT THEREOF, AND COMBINED DRUG THEREOF

TRANSIENT EXPRESSION SYSTEM FOR RNA, FOR VACCINATION

COMPOSITIONS, KITS, AND METHODS OF IMMUNIZING AGAINST VIRAL INFECTIONS

INTRANASAL POLYSACCHARIDE CONJUGATE NANOMULSION VACCINES AND METHODS OF USING THE SAME

INFLUENZA VIRUS VACCINES AND USES THEREOF

PREFUSION RSV F PROTEINS AND THEIR USE

COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS

FLAVIVIRUS IMMUNOGENS AND VACCINE COMPOSITIONS AND METHODS OF USING THE SAME

RECOMBINANT VACCINE AGAINST COVID-19 TO PRODUCE CELLULAR RESPONSE IN INDIVIDUALS WITH PRE-EXISTING IMMUNITY

PREFUSION RSV F PROTEINS AND THEIR USE

NUCLEIC ACID VACCINE AGAINST MONKEYPOX VIRUS AND USE THEREOF

ENHANCED EXPRESSION VIA AUTOTRANSPORTERS

NOVEL VACCINES FOR TUBERCULOSIS

VACCINE COMPOSITION

LIVE-ATTENUATED SARS-COV-2 VACCINE

PIV5-BASED COVID-19 VACCINE

TREHALOSE-BASED SURFACTANTS

RE-FOCUSING PROTEIN BOOSTER IMMUNIZATION COMPOSITIONS AND METHODS OF USE THEREOF

METHOD FOR ENHANCING IMMUNITY

LIVE ATTENUATED SARS-COV-2 AND A VACCINE MADE THEREOF

TREATMENT AND PREVENTION OF VIRAL INFECTIONS

CROSS-LINKED TUMOR LYSATE SPHERICAL NUCLEIC ACIDS AS CANCER VACCINES

IMMUNOSTIMULATORY PREPARATION AND COSMETIC, FOOD, FEED ADDITIVE, AND QUASI-PHARMACEUTICAL PRODUCT CONTAINING THE IMMUNOSTIMULATORY PREPARATION

ANTIBODIES AND METHODS OF USE

AVIAN INFLUENZA NANOPARTICLE IMMUNOGENIC COMPOSITIONS

COMPOSITIONS AND METHODS FOR MUCOSAL VACCINATION AGAINST SARS-COV-2

MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS

RECOMBINANT NEWCASTLE DISEASE VIRUSES AND IMMUNOGENIC COMPOSITIONS FOR USE IN IMMUNIZING AGAINST SARS-COV-2 OMICRON VARIANT

RESPIRATORY SYNCYTIAL VIRUS RECOMBINANT FUSION PROTEIN WITH PRE-FUSION CONFORMATION, PREPARATION METHOD AND USES THEREOF

TUBERCULOSIS VACCINES

CO-EXPRESSION OF CONSTRUCTS AND IMMUNOSTIMULATORY COMPOUNDS

TREATMENT AND PREVENTION OF CONDITIONS ASSOCIATED WITH RESPIRATORY DISEASES

VACCINE COMPOSITION COMPRISING AN ANTIGEN AND A TLR3 AGONIST

SARS-COV-2 NEUTRALIZING SYNTHETIC PROTEINS

INTERFERON-PRODUCING UNIVERSAL SARBECOVIRUS VACCINES, AND USES THEREOF

METHODS AND COMPOSITIONS FOR VACCINATION AGAINST HETEROSUBTYPIC INFLUENZA VIRUSES USING AN ADENOVIRAL VECTOR LEADING TO ENHANCED T CELL RESPONSE THROUGH AUTOPHAGY

INTRANASAL IMMUNOGENIC COMPOSITIONS

GLYCATED CHITOSANS FOR TREATMENT OF VIRAL INFECTIONS

COMPOSITIONS AND METHODS FOR VACCINATION AGAINST PATHOGENIC CORONAVIRUS SPECIES AND VARIANTS

METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER

VACCINE FOR EQUINE HERPESVIRUS

Viral Vaccines

BOOSTING SARS-COV-2 IMMUNITY WITH A LENTIVIRAL-BASED NASAL VACCINE

INFLUENZA VIRUS MUTANTS AND USES THEREFOR

OPTIMIZED MULTIDIMENSIONAL BIOLOGICAL ACTIVITY OF POLY-ICLC WITH CONTROLLED COMPONENT SIZE AND FORMULATION

METHODS FOR DESIGNING IMMUNOTHERAPIES AND TREATMENTS USING SAME

A SARS-COV-2 Human Parainfluenza Virus Type 3-Vectored Vaccine

VACCINE COMPOSITION

Multicistronic Vaccine and Methods for Producing and Using the Same

Attenuated Bordetella Strains

NASAL VACCINE-SPRAYING FORMULATION FOR SIMULTANEOUSLY TARGETING NASAL MUCOSA AND NASOPHARYNX

NOROVIRUS VACCINE AND METHODS OF USE

NOVEL ANTI-IL-36R ANTIBODIES

INTRANASAL VACCINE COMPOSITION AND METHOD FOR BOOSTING USING THE SAME

PNEUMOCOCCAL POLYPEPTIDE ANTIGENS

COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY

CORONAVIRUS FUSION PROTEIN

MUCOSAL VACCINE, METHODS OF USE AND ADMINISTRATION THEREOF

RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE

CHIMERIC VECTORS

J PARAMYXOVIRUS VACCINES

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

VACCINE COMPOSITION FOR PREVENTION AGAINST COVID-19

NOVEL VACCINE FORMULATIONS FOR MYCOBACTERIUM TUBERCULOSIS AND USE OF THEREOF

ALLERGY TREATMENT

RIBONUCLEOPROTEIN NANOCOMPLEX VACCINES AND USES THEREOF

ORAL VACCINE VIA DENTAL BACTERIA AND EMITTED PEPTIDES TO PREVENT INFECTION FROM A PATHOGEN

SYNERGISM OF IMMUNOGENICITY VIA COMBINED PARENTERAL AND MUCOSAL IMMUNIZATION AGAINST COVID-19

RECOMBINANT VIRUS CONTAINING DEGRON, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

GUT BACTERIA DERIVED MICROVESICLES FOR VACCINE DELIVERY

Method of Conferring a Protective Immune Response to Norovirus

COMPOSITIONS AND METHODS OF TREATING SARCOMA LUNG METASTASIS

DEOPTIMIZED SARS-COV-2 VARIANTS AND METHODS AND USES THEREOF

BOVINE COLOSTRUM DERIVED ANTIBODIES AND USES THEREOF

REPLICATION-COMPETENT ADENOVIRUS TYPE 4 SARS-COV-2 VACCINES AND THEIR USE

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

MODIFIED PIV5 VACCINE VECTORS: METHODS OF MAKING AND USES

COMPOSITIONS AND METHODS FOR TREATING CANCER

ADJUVANT AND VACCINE CONTAINING ADJUVANT

COMBINED AGONIST ADJUVANT FOR CORONAVIRUS VACCINE

LIVE-ATTENUATED VIRUS VACCINE

ORAL VACCINE VIA DENTAL BACTERIA AND EMITTED PEPTIDES TO PREVENT COVID-19 INFECTION

COMPOSITIONS AND METHODS FOR MUCOSAL VACCINATION AGAINST SARS-COV-2

Highly Attenuated Replication-Competent Recombinant Poxvirus As A Vaccine Platform And Methods Of Use

PEPTIDES DERIVED FROM ACINETOBACTER BAUMANNII AND THEIR USE IN VACCINATION

PERIODONTITIS VACCINE AND RELATED COMPOSITIONS AND METHODS OF USE

Prefusion RSV F proteins and their use

TOLL-LIKE RECEPTOR AGONIST-NANOPARTICLE VACCINE ADJUVANT

RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING SARS-COV-2 SPIKE PROTEIN AND ITS USE

RECOMBINANT PROTEIN CAPABLE OF RESISTING MULTIPLE SCLEROSIS AND PREPARATION METHOD AND APPLICATION THEREOF

EXTENDED-RANGE SPRAY APPLICATOR

INFLUENZA VACCINE FOR INTRANASAL ADMINISTRATION

NANOGEL-COATED VACCINE

METHOD OF ELICITING AN IMMUNE RESPONSE AGAINST RESPIRATORY SYNCYTIAL VIRUS

OPTIMAL PRODUCTION OF SARS-COV-2 VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN MAMMALIAN CELLS

LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS HETEROLOGOUS OUTER MEMBRANE PROTEIN ANTIGENS AND METHODS OF USE THEREOF

Compositions And Methods Of MAIT Cell Activation

CONSTRUCTS COMPRISING SINGLE DOMAIN VHH ANTIBODIES AGAINST SARS COV-2

RECOMBINANT RSV VACCINE: METHODS OF MAKING AND USING THE SAME

Interferon-producing universal sarbecovirus vaccines, and uses thereof

Periodontitis vaccine and related compositions and methods of use

TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BY INTRANASAL ADMINISTRATION OF IMMUNOGLOBULIN G

PHARMACEUTICAL COMPOSITION COMPRISING TOLL-LIKE RECEPTOR AGONIST AND STIMULATOR OF INTERFERON GENES AGONIST AND USE THEREOF

Immunogenic compositions and uses thereof

FUSION PROTEIN AND VACCINE

NANOEMULSION COMPOSITIONS FOR PREVENTING, SUPPRESSING OR ELIMINATING ALLERGIC AND INFLAMMATORY DISEASE

Hepatitis C virus immunogenic compositions and methods of use thereof

TRANSIENT EXPRESSION SYSTEM FOR RNA, FOR VACCINATION

Vaccine booster compositions for respiratory viral diseases

Prefusion RSV F proteins and their use

Influenza vaccines

TRANSMUCOSAL AMPHIPHILE-PROTEIN CONJUGATE VACCINE

COXIELLA BURNETII AVIRULENT NINE MILE PHASE II VIABLE BACTERIA AND METHODS OF USE

VIRAL VACCINE COMPOSITIONS FOR INOCULATING A SUBJECT AGAINST A CORONAVIRUS, AN INFLUENZA VIRUS, OR BOTH

INFLUENZA VIRUSES WITH MUTANT PB2 GENE SEGMENT AS LIVE ATTENUATED VACCINES

FcRn-targeted mucosal vaccination against influenza infections

MATERIALS AND METHODS FOR MITIGATING IMMUNE-SENSITIZATION

METHODS AND COMPOSITIONS FOR INCREASING IMMUNITY AGAINST CORONAVIRUSES

LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS

Post-Exposure Vaccination Against Viral Respiratory Infections

RSV VACCINE COMPOSITIONS, METHODS, AND USES THEREOF

INTRANASAL VACCINES AND THERAPEUTICS FOR RESPIRATORY DISEASES

HIV VACCINE COMPOSITIONS, METHODS, AND USES THEREOF

Methods of permeabilizing the blood brain barrier

ANTI-INFECTION AND ANTI-TUMOR MUCOSAL IMMUNE PREPARATION

INFLUENZA VIRUS-LIKE PARTICLES (VLPS)

ADJUVANTED CONJUGATE OPIOID VACCINE

Use of the Salmonella SPP Type III Secretion Proteins as a Protective Vaccination

DESIGNER PEPTIDES AND PROTEINS FOR THE DETECTION, PREVENTION AND TREATMENT OF CORONAVIRUS DISEASE, 2019 (COVID-19)

Coronavirus vaccine compositions, methods, and uses thereof

INTRANASAL mRNA VACCINES

Influenza virus vectors and uses therefor

RECOMBINANT NOVEL CORONAVIRUS VACCINE USING REPLICATION-DEFICIENT HUMAN ADENOVIRUS AS VECTOR

Influenza virus mutants and uses therefor

NOVEL PRIME-BOOST INFLUENZA VACCINE

COMPOSITIONS AND METHODS FOR PRODUCING ENHANCED IMMUNE RESPONSES AND RAPID ANTIBODY PRODUCTION

COMPOSITIONS AND METHODS USEFUL FOR EBOLA VIRUS INFECTION

Therapeutic Agent Effectiveness and its Route of Adminstration

Paramyxovirus vaccine strain for novel coronavirus pneumonia and construction method thereof

LIVE ATTENUATED ORAL VACCINE AGAINST SHIGELLOSIS AND TYPHOID FEVER

Immunogenic Antigens

RECOMBINANT ADENOVIRUS VACCINE FOR CORONA VIRUS DISEASE 19 AND COMBINATION THERAPY USING THE SAME

UNIVERSAL VACCINES AGAINST IMMUNOGENS OF PATHOGENIC ORGANISMS THAT PROVIDE ORGANISM-SPECIFIC AND CROSS-GROUP PROTECTION

Composition and method for spray drying an adjuvant vaccine emulsion

INFLUENZA VIRUS BACKBONE

Recombinant chimeric bovine/human parainfluenza virus 3 expressing rsv g and its use

VIRAL VACCINES AND METHODS OF FORMING THE SAME

MOMP telonanoparticles, and related compositions, methods and systems

Method of treating, reducing, or alleviating a medical condition in a patient

Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis B virus

Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses

INFLUENZA VACCINE COMPOSITION BASED ON NOVEL NUCLEIC ACID

Method of conferring a protective immune response to Norovirus

Recombinant influenza viruses and constructs and uses thereof

IMMUNOSTIMULATORY BACTERIA-BASED VACCINES, THERAPEUTICS, AND RNA DELIVERY PLATFORMS

Compositions for preventing or treating viral and other microbial infections

Immunogenic Antigens

Immunogen for broad-spectrum influenza vaccine and application thereof

ANTIBODIES USEFUL IN PASSIVE INFLUENZA IMMUNIZATION, AND COMPOSITIONS, COMBINATIONS AND METHODS FOR USE THEREOF

Gut bacteria derived microvesicles for vaccine delivery

Compositions and methods for mucosal vaccination against SARS-CoV-2

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

Antigen Delivery Vectors and Constructs

Coronavirus immunogenic compositions and uses thereof

Prefusion RSV F proteins and their use

Bovine herpesvirus type 1 (BoHV-1) vector against bovine respiratory disease complex

Alphavirus nsP mutants as vaccines

Coronavirus vaccine compositions, methods, and uses thereof

Influenza vaccines

Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease

Compositions and methods of treating sarcoma lung metastasis

Pharmaceutical composition comprising attenuated strains and use thereof

Multivalent live influenza vaccine platform using recombinant adenovirus

Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

Periodontitis vaccine and related compositions and methods of use

TARGETING moDC TO ENHANCE VACCINE EFFICACY ON MUCOSAL SURFACE

CD131 binding proteins and uses thereof

Rapid and prolonged immunologic-therapeutic

CORONAVIRUS IMMUNOGENIC COMPOSITIONS AND USES THEREOF

CORONAVIRUS IMMUNOGENIC COMPOSITIONS AND USES THEREOF

Vaccines comprising mutant attenuated influenza viruses

Virus-like particles co-expressing IMC, ROP18, and MIC8, and pharmaceutical composition comprising the same

RECOMBINANT NEWCASTLE DISEASE VIRUSES AND USES THEREOF FOR THE PREVENTION OF RSV DISEASE OR HUMAN METAPNEUMOVIRUS DISEASE

Extended-range spray applicator

Chimeric vectors

Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration

Hepatitis C virus immunogenic compositions and methods of use thereof

Streptococcal vaccine

Recombinant chimeric bovine/human parainfluenza virus 3 expressing RSV G and its use

Live attenuated Arkansas serotype infectious bronchitis virus vaccine

ADJUVANT AND VACCINE CONTAINING ADJUVANT

RESPIRATORY SYNCYTIAL VIRUS VACCINE

Treatment of central nervous system disorders by intranasal administration of immunoglobulin g

Broadly protective inactivated influenza virus vaccine

Vaccine treatment and control infectious against viral pathogens utilizing heparan sulfate (HS) as cellular receptor

Tuberculosis vaccine, preparation method therefor, and use thereof

Fungal immunogens and related materials and methods

Immunogenic compositions comprising surface proteins and uses thereof

METHOD FOR TREATING SEIZURES

Influenza virus vectors and uses therefor

Vaccine composition against infection

Live attenuated oral vaccine against ETEC and typhoid fever

Liquid vaccines of live enveloped viruses

CHIKV RNA vaccines

Immunogenic compositions and uses thereof

Method of conferring a protective immune response to norovirus

Rapid and prolonged immunogic therapeutic

Rapid and prolonged immunologic therapeutic

Intranasal delivery of a cyclic-di-nucleotide adjuvanted vaccine for tuberculosis

Fusion proteins and combination vaccines comprising Protein E and Pilin A

Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses

Synthetic hemagglutinin as universal vaccine against infection by type B influenza viruses (IBV)

Use of the salmonella SPP type III secretion proteins as a protective vaccination

Binding molecules directed against influenza hemagglutinin and uses thereof

Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis B virus

Fungal immunogens and related materials and methods

Recombinant respiratory syncytial virus strains with mutations in the M2-2 ORF providing a range of attenuation phenotypes

Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

Pharmaceutical composition comprising attenuated strains and use thereof

Peptides derived from and their use in vaccination

Influenza viruses with mutant PB2 gene segment as live attenuated vaccines

INTRAVENOUS IMMUNOGLOBULIN COMPOSITIONS SPECIFIC FOR RESPIRATORY SYNCYTIAL VIRUS AND METHODS OF MAKING AND USING THE SAME

Methods and compositions employing immunogenic fusion proteins

Immunogenic proteins against

Bordetella vaccine

Rabbit coccidiosis vaccine and application thereof

Live vectors engineered to express heterologous outer membrane protein antigens and methods of use thereof

Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine

Attenuated strains

METHODS OF SUPPRESSING MICROGLIAL ACTIVATION

Fungal immunogens and related materials and methods

Attenuated african swine fever virus vaccine

Immunogenic Cedar Virus compositions

Nanoemulsion and methods of use thereof

Antigenic combinations against bacteria and related nanolipoprotein particles, compositions, methods and systems

Compositions comprising an anti-C5 antibody

Intranasal vector vaccine against porcine epidemic diarrhea

Compositions and methods for enhancing innate immunity in a subject for treatment of infections and cancer and other acute and chronic conditions of the eye

Influenza virus mutants and uses therefor

Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof

MOMP telonanoparticles, and related compositions, methods and systems

Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus

COMPOSITIONS OF MULTIMERIC-MULTIEPITOPE INFLUENZA POLYPEPTIDES AND THEIR PRODUCTION

Method of conferring a protective immune response to norovirus

Ex vivo antigen and adjuvant pulsed peripheral blood mononuclear cells as a screening platform for candidate novel vaccines and candidate antigens

Binding molecules directed against influenza hemagglutinin and uses thereof

Alphavirus NSP mutants as vaccines

FcRn-targeted mucosal vaccination against influenza infections

Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein A

Immunostimulatory compositions and uses therefor

Functional influenza virus like particles (VLPs)

Immunogenic compositions and uses thereof

Meningococcal infection and modified

Composition for enhancing induction of humoral immunity, and vaccine pharmaceutical composition

Chlamydia antigens

Composition comprising antigens and a mucosal adjuvant and a method for using

Hepatitis C virus immunogenic compositions and methods of use thereof

Composition comprising antigens and a mucosal adjuvant and a method for using

Influenza mucosal vaccine composition and preparation and application thereof

Recombinant mumps virus vaccine

Transgenic VERO-CD4/CCR5 cell line

Recombinant protein delivered as nanoparticles

Tobacco products

Optimized HIV envelope gene and expression thereof

Microparticulated Vaccines for the Oral or Nasal Vaccination and Boostering of Animals Including Fish

Periodontitis vaccine and related compositions and methods of use

Live attenuated recombinant HMPV with mutations in PDZ motifs of M2-2 protein, vaccine containing and use thereof

Recombinant influenza virus-like particles (VLPS) produced in transgenic plants

Attenuated strains

Albumin variants and uses thereof

RAPID AND PROLONGED IMMUNOGENIC-THERAPEUTIC

Nanoemulsion adjuvant for nasal mucosa and preparation method thereof

INFLUENZA VIRUS VACCINATION REGIMENS

Norovirus vaccine formulations

Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine

Vaccines comprising mutant attenuated influenza viruses

Substitutions-modified prefusion RSV F proteins and their use

Influenza virus vaccines and uses thereof

Artificial invaplex formulated with deacylated lipopolysaccharide

Compositions comprising an anti-C5 antibody

NASAL INFLUENZA VACCINE COMPOSITION

RESPIRATORY SYNCYTIAL VIRUS VACCINE

HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS

Method for inhibiting, improving, or preventing aging using recombinant fusion protein of pathogenic antigen protein and flagellin of

Gonorrheal MtrE peptides and vaccines

CD131 binding proteins

Influenza virus mutants and uses therefor

Infectious disease vaccines

TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BY INTRANASAL ADMINISTRATION OF IMMUNOGLOBULIN G